Why the study?
Does T-lymphocyte depletion alter the incidence or severity of hyperglycemia in EMC-M virus-infected DBA/2 and Balb/cBY mice?
Does T-lymphocyte depletion alter the incidence or severity of hyperglycemia in EMC-M virus-infected DBA/2 and Balb/cBY mice?
The study demonstrates that the pathogenesis of EMC-M virus-induced diabetes in mice is genetically influenced, with some strains experiencing direct viral beta-cell injury and others experiencing compounded immunologic damage.
Answers are grounded in this paper and cite their sources.
Strain-specific T-cell depletion responses in mice caution against broad immune therapies; leaves open genetic stratification for future diabetes models.
DBA/2 and Balb/cBY mice were infected with approximately 30 plaque-forming units of the M-variant of encephalomyocarditis (EMC-M) virus. Seven days after inoculation the majority of the animals of both strains were hyperglycemic. A significant correlation between increased concentrations of virus in the pancreas and hyperglycemia was found among individual DBA/2 animals, but not among Balb/cBY mice. T-lymphocyte depletion of DBA/2 mice before infection failed to alter the incidence or severity of hyperglycemia in comparison to intact animals. Conversely, hyperglycemia in T-lymphocyte-depleted Balb/cBY mice was reduced substantially in comparison to infected immunocompetent animals. There appears to be at least two genetically influenced pathogenic mechanisms of diabetes in EMC-M virus-infected mice. In some strains of animals, hyperglycemia results exclusively from viral infection and the consequent injury to the beta cells, whereas in other animals, viral damage to the islets is compounded by immunologic events.
No takes yet. Share an insight, caveat, or question.
Huber et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: